Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Antipsychotic-induced immune dysfunction: A consideration for COVID-19 risk

Brain Behavior & Immunity - Health(2020)10.1016/j.bbih.2020.100097Source: DataRank Database

Antipsychotic-induced immune dysfunction: A consideration for COVID-19 risk is a research paper published in Brain Behavior & Immunity - Health (2020). On theSindex it has a DataRank of 0. It has been cited 40 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access40 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.56)OA: goldTopics (29)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Matthew Slitzky,Bahman Rostama ORCID,Deborah Barlow,Karen L. Houseknecht ORCID,Meghan May ORCID

Live enrichment

PubMed:32835296 PMC:PMC7308744 OpenAlex:https://openalex.org/W3036512435

NIGMS Award

Grant: P20GM103643

NIDDK Award

Grant: DK095143

National Institutes of Health

Grant: 5P20GM103643-04

Project 1: Cao

National Institutes of Health

FWCI

1.56

Citation Percentile

0.8%

Citation Trend

2020

2021

2022

2023

2024

2025

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.bbih.2020.100097

GOLDhttps://doi.org/10.1016/j.bbih.2020.100097

publisherhttps://doi.org/10.1016/j.bbih.2020.100097

publisherhttps://api.elsevier.com/content/article/PII:S2666354620300624?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666354620300624?httpAccept=text/plain

Fields of Study

Tryptophan and brain disordersPharmacological Receptor Mechanisms and EffectsCOVID-19 Clinical Research StudiesMedicine03 medical and health sciences0302 clinical medicine

Keywords

MedicineIrritabilitySchizophrenia (object-oriented programming)AntipsychoticMental illnessImmune systemRisperidoneDepression (economics)DiseaseImmune dysregulationPsychiatryInternal medicineImmunologyMental healthAnxietyInfectionCytokineInflammationPneumoniaadaptive immunityShort CommunicationNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Antipsychotic-induced immune dysfunction: A consideration for COVID-19 risk

FAIR Checklist

Authors (5)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)